Archive for June, 2008
Acomplia linked to 5 deaths in the UK
Posted on June 22, 2008 - Filed Under Acomplia | Leave a Comment
Five lives have been claimed and 720 adverse drug reactions have occurred in Britain since the launch of France’s Sanofi-Aventis SA’s weight-loss drug, Acomplia, two years ago; this, according to a posting on the United Kingdom’s drug regulator’s Website this week. Acomplia—known generically as rimonabant—had been slated to be a multi-billion dollar seller; however, following [...]
Sanofi publishes a positive study.
Posted on June 2, 2008 - Filed Under Weight Loss | Leave a Comment
Sanofi-aventis publishes positive judged results of his study Athena on the Multaq, his treatment of the fibrillation little finger, a disturbance of the cardiac rhythm being able to provoke vascular cerebral accidents.
The study presented to the Corporation of American Cardiac Rythmologie was realized in blind double, on 4,628 recruited patients in 37 countries.
His vocation was [...]
